Gossamer Bio, Inc. (Nasdaq: GOSS), a biopharmaceutical company focusing on the clinical...
Remix Therapeutics, a biotechnology company in the clinical stage, is pioneering the de...
Amolyt Pharma has received Fast Track designation from the FDA for its Phase 3 developm...
Tenax Therapeutics, Inc. (Nasdaq: TENX) has announced that the United States Patent and...
Wave Life Sciences Ltd. has announced the approval of its first clinical trial applicat...
X4 Pharmaceuticals announced today that the U.S. Food and Drug Administration has appro...
AEON Biopharma, Inc., a clinical-stage biopharmaceutical company focused on developing a p...
Alpha-9 Oncology, a clinical stage company developing radiopharmaceuticals for the treatme...
Arrowhead Pharmaceuticals, Inc. today announced a $50 million milestone payment was receiv...
Arsenal Biosciences, Inc., a clinical stage programmable cell therapy company focused on e...
The analytical lab equipments or instruments are used in analytical applications in pharmaceutical, food-processing laboratories, chemical, clinical, and oil refineries. These lab equipments or instruments help in analyzing materials and setting up the composition. The most common types of analytical lab equipments are calorimeter, spectrophotometer, electrochemical instrument, refractometer, colony counter, automatic density meter, fiberscopes, conductivity meter, demagnetizers, automatic titrators, and several others
Packaging machinery is one of the vital equipment in the pharmaceutical industry, food processing, and chemical industries among which blister packaging machines are widely used for packaging capsules, pills, tablets, suppositories, etc. We can get an effective and safe packaging of tablets from a tablet press or capsules from capsule filling with the help of a blister packing machine. The blister packing machine is designed for packing the different products
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this is to arrive at enhanced efficacy and improve patient compliance. As the topical administration of drugs through conventional dosage structures, for example, solutions, creams, etc to the eyes is related to the low bioavailability (under 5%), and consequently, we can't rely upon these for conveying medications to eyes all the more productively
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product i.e. tablet, capsule. Generally, drug products are included with various components. Among them, Active Pharmaceutical Ingredient (API) is the primary ingredient. Other ingredients in drug products are known as 'excipients'. These substances, which make up a variable fraction of the drug product , are required to be biologically safe. The procedure for optimizing and composting the mixture of components
Focus on drug discovery and development has shifted away from small to large, complex molecular entities to therapeutic biologics. Biotherapeutics play a significant role in combating cancer, diabetes and autoimmune diseases. Recently, Biotherapeutics spread in to the areas of genetic disorder, regenerative therapy, and personalized medicine. The biopharma sector has witnessed an incredible growth with the total annual revenue has increased from about US$4.4 billion
Revolutionizing Medicine: Harnessing the Power of AI in Clinical Trials and Quality Management Systems
Addressing challenges in global supply chain logistics.
Exploring Innovations and Opportunities in the EU CMC Market: A Deep Dive into API and FDF Solutions
Bhupinder Singh Interview - CEO at Messe Muenchen India Pvt. Ltd.
Manel Chikh Interview - CEO at Zaphyr Pharmaceuticals
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for c...
Aptar Pharma plans to expand its manufacturing capacity and capabilities in New York, USA.
Pharmascience, the largest Canadian-owned pharmaceutical company, announced a major $120 million sterile injectable manufacturing facility expansion a...
AbbVie invests US$223 million to expand biologics manufacturing capacity in Singapore. This new investment will increase an additional 24,000 litres o...